222 related articles for article (PubMed ID: 28583308)
1. An epitope-specific DerG-PG70 LEAPS vaccine modulates T cell responses and suppresses arthritis progression in two related murine models of rheumatoid arthritis.
Mikecz K; Glant TT; Markovics A; Rosenthal KS; Kurko J; Carambula RE; Cress S; Steiner HL; Zimmerman DH
Vaccine; 2017 Jul; 35(32):4048-4056. PubMed ID: 28583308
[TBL] [Abstract][Full Text] [Related]
2. Vaccination by Two DerG LEAPS Conjugates Incorporating Distinct Proteoglycan (PG, Aggrecan) Epitopes Provides Therapy by Different Immune Mechanisms in a Mouse Model of Rheumatoid Arthritis.
Zimmerman DH; Mikecz K; Markovics A; Carambula RE; Ciemielewski JC; Toth DM; Glant TT; Rosenthal KS
Vaccines (Basel); 2021 May; 9(5):. PubMed ID: 34063326
[TBL] [Abstract][Full Text] [Related]
3. Proteoglycan-induced arthritis and recombinant human proteoglycan aggrecan G1 domain-induced arthritis in BALB/c mice resembling two subtypes of rheumatoid arthritis.
Glant TT; Radacs M; Nagyeri G; Olasz K; Laszlo A; Boldizsar F; Hegyi A; Finnegan A; Mikecz K
Arthritis Rheum; 2011 May; 63(5):1312-21. PubMed ID: 21305522
[TBL] [Abstract][Full Text] [Related]
4. Immune Recognition of Citrullinated Proteoglycan Aggrecan Epitopes in Mice with Proteoglycan-Induced Arthritis and in Patients with Rheumatoid Arthritis.
Markovics A; Ocskó T; Katz RS; Buzás EI; Glant TT; Mikecz K
PLoS One; 2016; 11(7):e0160284. PubMed ID: 27466816
[TBL] [Abstract][Full Text] [Related]
5. The role of citrullination of an immunodominant proteoglycan (PG) aggrecan T cell epitope in BALB/c mice with PG-induced arthritis.
Misják P; Bősze S; Horváti K; Pásztói M; Pálóczi K; Holub MC; Szakács F; Aradi B; György B; Szabó TG; Nagy G; Glant TT; Mikecz K; Falus A; Buzás EI
Immunol Lett; 2013 Apr; 152(1):25-31. PubMed ID: 23578666
[TBL] [Abstract][Full Text] [Related]
6. Rheumatoid arthritis vaccine therapies: perspectives and lessons from therapeutic ligand epitope antigen presentation system vaccines for models of rheumatoid arthritis.
Rosenthal KS; Mikecz K; Steiner HL; Glant TT; Finnegan A; Carambula RE; Zimmerman DH
Expert Rev Vaccines; 2015 Jun; 14(6):891-908. PubMed ID: 25787143
[TBL] [Abstract][Full Text] [Related]
7. CEL-2000: A therapeutic vaccine for rheumatoid arthritis arrests disease development and alters serum cytokine/chemokine patterns in the bovine collagen type II induced arthritis in the DBA mouse model.
Zimmerman DH; Taylor P; Bendele A; Carambula R; Duzant Y; Lowe V; O'Neill SP; Talor E; Rosenthal KS
Int Immunopharmacol; 2010 Apr; 10(4):412-21. PubMed ID: 20074669
[TBL] [Abstract][Full Text] [Related]
8. Increased arthritis susceptibility in cartilage proteoglycan-specific T cell receptor-transgenic mice.
Berlo SE; Guichelaar T; Ten Brink CB; van Kooten PJ; Hauet-Broeren F; Ludanyi K; van Eden W; Broeren CP; Glant TT
Arthritis Rheum; 2006 Aug; 54(8):2423-33. PubMed ID: 16869010
[TBL] [Abstract][Full Text] [Related]
9. Continuous nasal administration of antigen is critical to maintain tolerance in adoptively transferred autoimmune arthritis in SCID mice.
Bárdos T; Czipri M; Vermes C; Zhang J; Mikecz K; Glant TT
Clin Exp Immunol; 2002 Aug; 129(2):224-31. PubMed ID: 12165077
[TBL] [Abstract][Full Text] [Related]
10. Induction of arthritis in SCID mice by T cells specific for the "shared epitope" sequence in the G3 domain of human cartilage proteoglycan.
Hanyecz A; Bárdos T; Berlo SE; Buzás E; Nesterovitch AB; Mikecz K; Glant TT
Arthritis Rheum; 2003 Oct; 48(10):2959-73. PubMed ID: 14558103
[TBL] [Abstract][Full Text] [Related]
11. Cartilage proteoglycan aggrecan epitopes induce proinflammatory autoreactive T-cell responses in rheumatoid arthritis and osteoarthritis.
de Jong H; Berlo SE; Hombrink P; Otten HG; van Eden W; Lafeber FP; Heurkens AH; Bijlsma JW; Glant TT; Prakken BJ
Ann Rheum Dis; 2010 Jan; 69(1):255-62. PubMed ID: 19213744
[TBL] [Abstract][Full Text] [Related]
12. Current status of immunological therapies for rheumatoid arthritis with a focus on antigen-specific therapeutic vaccines.
Zimmerman DH; Szekanecz Z; Markovics A; Rosenthal KS; Carambula RE; Mikecz K
Front Immunol; 2024; 15():1334281. PubMed ID: 38510240
[TBL] [Abstract][Full Text] [Related]
13. Th1/Th17 polarization and acquisition of an arthritogenic phenotype in arthritis-susceptible BALB/c, but not in MHC-matched, arthritis-resistant DBA/2 mice.
Boldizsar F; Tarjanyi O; Nemeth P; Mikecz K; Glant TT
Int Immunol; 2009 May; 21(5):511-22. PubMed ID: 19254958
[TBL] [Abstract][Full Text] [Related]
14. Proteoglycan aggrecan conducting T cell activation and apoptosis in a murine model of rheumatoid arthritis.
Hanyecz A; Olasz K; Tarjanyi O; Nemeth P; Mikecz K; Glant TT; Boldizsar F
Biomed Res Int; 2014; 2014():942148. PubMed ID: 24605340
[TBL] [Abstract][Full Text] [Related]
15. Predominant cellular immune response to the cartilage autoantigenic G1 aggrecan in ankylosing spondylitis and rheumatoid arthritis.
Zou J; Zhang Y; Thiel A; Rudwaleit M; Shi SL; Radbruch A; Poole R; Braun J; Sieper J
Rheumatology (Oxford); 2003 Jul; 42(7):846-55. PubMed ID: 12730543
[TBL] [Abstract][Full Text] [Related]
16. Construction and characterization of a novel DNA vaccine that is potent antigen-specific tolerizing therapy for experimental arthritis by increasing CD4+CD25+Treg cells and inducing Th1 to Th2 shift in both cells and cytokines.
Song X; Liang F; Liu N; Luo Y; Xue H; Yuan F; Tan L; Sun Y; Xi C; Xi Y
Vaccine; 2009 Jan; 27(5):690-700. PubMed ID: 19095031
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effect of human amniotic membrane-derived cells on experimental arthritis and other inflammatory disorders.
Parolini O; Souza-Moreira L; O'Valle F; Magatti M; Hernandez-Cortes P; Gonzalez-Rey E; Delgado M
Arthritis Rheumatol; 2014 Feb; 66(2):327-39. PubMed ID: 24504805
[TBL] [Abstract][Full Text] [Related]
18. B cells expressing IFN-γ suppress Treg-cell differentiation and promote autoimmune experimental arthritis.
Olalekan SA; Cao Y; Hamel KM; Finnegan A
Eur J Immunol; 2015 Apr; 45(4):988-98. PubMed ID: 25645456
[TBL] [Abstract][Full Text] [Related]
19. Green tea EGCG, T cells, and T cell-mediated autoimmune diseases.
Wu D; Wang J; Pae M; Meydani SN
Mol Aspects Med; 2012 Feb; 33(1):107-18. PubMed ID: 22020144
[TBL] [Abstract][Full Text] [Related]
20. Development of proteoglycan-induced arthritis depends on T cell-supported autoantibody production, but does not involve significant influx of T cells into the joints.
Angyal A; Egelston C; Kobezda T; Olasz K; László A; Glant TT; Mikecz K
Arthritis Res Ther; 2010; 12(2):R44. PubMed ID: 20298547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
